KAITLIN KELLAR: Open Payments
NPI 1700660255 · COVINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$146 in 8 payments from 5 companies in 2025. Trend: 2023 $17 · 2024 $415 · 2025 $146
Food & beverage: $146
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $49 |
| MILLICENT US INC | 2 | $33 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $29 |
| CooperSurgical, Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
Products named: Veozah, Paragard T 380A, FEMRING, INTRAROSA, MYFEMBREE.
Industry payments across LA — which companies pay providers there.
